Purpose Of Review: Syringe access programs (SAPs) are cornerstone harm reduction interventions for combatting the national opioid epidemic. The goal of this paper is to describe effective advocacy strategies for enacting syringe decriminalization legislation to foster the expansion of SAPs in high-need areas amidst political opposition.
Recent Findings: Decades or research shows that SAPs prevent the transmission of HIV among people who inject drugs (PWID) and are a cost-effective tool for linking PWID to medical care, health education, and social services. In the USA, state laws criminalizing distribution and possession of syringes impede the expansion of SAPs into areas where they are sorely needed. In 2016, North Carolina became the first state to legalize SAPs with a Republican super majority. This paper distills strategies for community organizations seeking to advance syringe decriminalization legislation in politically conservative states with histories of prioritizing punitive sanctions over public health responses to drug use.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11904-018-0397-9 | DOI Listing |
Lancet Reg Health Am
February 2024
Division of Infectious Diseases and Global Public Health, University of California, San Diego, CA, USA.
Background: Incarceration is associated with drug-related harms among people who inject drugs (PWID). We trained >1800 police officers in Tijuana, Mexico on occupational safety and HIV/HCV, harm reduction, and decriminalization reforms (Proyecto Escudo). We evaluated its effect on incarceration, population impact and cost-effectiveness on HIV and fatal overdose among PWID.
View Article and Find Full Text PDFArch Psychiatr Nurs
October 2023
The Janssen Pharmaceutical Companies of Johnson & Johnson, United States of America.
Introduction: Syringe decriminalization is a harm reduction approach to decrease deaths and disease related to drug use. The purpose of this study was to develop an understanding of the impact of syringe decriminalization on the harm reduction community in Pennsylvania.
Methods: Semi-structured interviews were conducted with ten participants identified as harm reduction experts.
J Am Pharm Assoc (2003)
January 2023
Despite large investments in and policy support for harm reduction including naloxone, syringes, and medications for opioid use disorder, people who use drugs continue to experience unprecedented rates of mortality from overdose and morbidity from infectious diseases. The criminalization of drug use has disproportionately exacerbated these drug-related harms and imposed short- and long-term burdens on already marginalized and vulnerable populations. Pharmacy professionals and students are not immune to the effects of drug criminalization, where one conviction can lead to the loss of their license, employment, or educational progress.
View Article and Find Full Text PDFInt J Drug Policy
August 2022
Global Health Research Center of Central Asia, Almaty, Kazakhstan; Columbia University School of Social Work, Columbia University, New York, NY, USA.
Introduction: Punitive legal environments remain a challenge to HIV prevention efforts in Central Asia, and female sex workers who use drugs are vulnerable to police violence. Little is known about the heterogeneity of police violence against female sex workers who use drugs and factors associated with HIV risk in Central Asia, despite the growing HIV epidemic.
Methods: We recruited a community-based sample of 255 female sex workers who use drugs in Almaty, Kazakhstan between February 2015 and May 2017.
Subst Use Misuse
June 2022
Maurer School of Law, Indiana University-Bloomington, Bloomington, Indiana, USA.
The U.S. is undergoing an opioid overdose crisis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!